Significance of incisional biopsy in breast carcinoma: Results from a clinical trial with intended excisional biopsy

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Significance of incisional biopsy in breast carcinoma : Results from a clinical trial with intended excisional biopsy. / Watt-Boolsen, S.; Ottesen, G.; Andersen, J. A.; Bayer, T.; Jespersen, N. C. B.; Keiding, N.; Mouridsen, H. T.; Dombernowsky, P.; Blichert-Toft, M.

In: European Journal of Surgical Oncology, Vol. 15, No. 1, 1989, p. 33-37.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Watt-Boolsen, S, Ottesen, G, Andersen, JA, Bayer, T, Jespersen, NCB, Keiding, N, Mouridsen, HT, Dombernowsky, P & Blichert-Toft, M 1989, 'Significance of incisional biopsy in breast carcinoma: Results from a clinical trial with intended excisional biopsy', European Journal of Surgical Oncology, vol. 15, no. 1, pp. 33-37.

APA

Watt-Boolsen, S., Ottesen, G., Andersen, J. A., Bayer, T., Jespersen, N. C. B., Keiding, N., Mouridsen, H. T., Dombernowsky, P., & Blichert-Toft, M. (1989). Significance of incisional biopsy in breast carcinoma: Results from a clinical trial with intended excisional biopsy. European Journal of Surgical Oncology, 15(1), 33-37.

Vancouver

Watt-Boolsen S, Ottesen G, Andersen JA, Bayer T, Jespersen NCB, Keiding N et al. Significance of incisional biopsy in breast carcinoma: Results from a clinical trial with intended excisional biopsy. European Journal of Surgical Oncology. 1989;15(1):33-37.

Author

Watt-Boolsen, S. ; Ottesen, G. ; Andersen, J. A. ; Bayer, T. ; Jespersen, N. C. B. ; Keiding, N. ; Mouridsen, H. T. ; Dombernowsky, P. ; Blichert-Toft, M. / Significance of incisional biopsy in breast carcinoma : Results from a clinical trial with intended excisional biopsy. In: European Journal of Surgical Oncology. 1989 ; Vol. 15, No. 1. pp. 33-37.

Bibtex

@article{db0215982add4b398b7f69ba062d7106,
title = "Significance of incisional biopsy in breast carcinoma: Results from a clinical trial with intended excisional biopsy",
abstract = "The recurrence-free survival rates (RFS) after one-stage mastectomy and partial axillary dissection in 1242 low risk breast cancer patients with invasive ductal carcinoma with or without residual cancer tissue (RCT) in the wall of the biopsy cavity were compared. RFS was significantly lower in patients with RCT (RCT-positive) whether premenopausal (n = 416) or postmenopausal (n = 826). By applying the Cox multivariate analysis on RCT and various known prognostic criteria, the incidence rates for RCT-positive patients relative to RCT-negative patients were estimated. The relative risk by RCT-positivity was in the order of 1.45, indicating that RCT is an independent risk factor contributing an increased risk of recurrence of about 45%.",
author = "S. Watt-Boolsen and G. Ottesen and Andersen, {J. A.} and T. Bayer and Jespersen, {N. C. B.} and N. Keiding and Mouridsen, {H. T.} and P. Dombernowsky and M. Blichert-Toft",
year = "1989",
language = "English",
volume = "15",
pages = "33--37",
journal = "European Journal of Surgical Oncology",
issn = "0748-7983",
publisher = "Elsevier",
number = "1",

}

RIS

TY - JOUR

T1 - Significance of incisional biopsy in breast carcinoma

T2 - Results from a clinical trial with intended excisional biopsy

AU - Watt-Boolsen, S.

AU - Ottesen, G.

AU - Andersen, J. A.

AU - Bayer, T.

AU - Jespersen, N. C. B.

AU - Keiding, N.

AU - Mouridsen, H. T.

AU - Dombernowsky, P.

AU - Blichert-Toft, M.

PY - 1989

Y1 - 1989

N2 - The recurrence-free survival rates (RFS) after one-stage mastectomy and partial axillary dissection in 1242 low risk breast cancer patients with invasive ductal carcinoma with or without residual cancer tissue (RCT) in the wall of the biopsy cavity were compared. RFS was significantly lower in patients with RCT (RCT-positive) whether premenopausal (n = 416) or postmenopausal (n = 826). By applying the Cox multivariate analysis on RCT and various known prognostic criteria, the incidence rates for RCT-positive patients relative to RCT-negative patients were estimated. The relative risk by RCT-positivity was in the order of 1.45, indicating that RCT is an independent risk factor contributing an increased risk of recurrence of about 45%.

AB - The recurrence-free survival rates (RFS) after one-stage mastectomy and partial axillary dissection in 1242 low risk breast cancer patients with invasive ductal carcinoma with or without residual cancer tissue (RCT) in the wall of the biopsy cavity were compared. RFS was significantly lower in patients with RCT (RCT-positive) whether premenopausal (n = 416) or postmenopausal (n = 826). By applying the Cox multivariate analysis on RCT and various known prognostic criteria, the incidence rates for RCT-positive patients relative to RCT-negative patients were estimated. The relative risk by RCT-positivity was in the order of 1.45, indicating that RCT is an independent risk factor contributing an increased risk of recurrence of about 45%.

UR - http://www.scopus.com/inward/record.url?scp=0024593218&partnerID=8YFLogxK

M3 - Journal article

C2 - 2537237

AN - SCOPUS:0024593218

VL - 15

SP - 33

EP - 37

JO - European Journal of Surgical Oncology

JF - European Journal of Surgical Oncology

SN - 0748-7983

IS - 1

ER -

ID: 202331414